Shi Yong Neo
Overview
Explore the profile of Shi Yong Neo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neo S, Shuen T, Khare S, Chong J, Lau M, Shirgaonkar N, et al.
JCI Insight
. 2025 Feb;
PMID: 39998891
The functional plasticity of tumor-infiltrating B (TIL-B) cells spans from anti-tumor responses to non-canonical immune suppression. Yet, how tumor microenvironment (TME) influences TIL-B development is still underappreciated. Our current study...
2.
Neo S, Tong L, Chong J, Liu Y, Jing X, Oliveira M, et al.
Sci Transl Med
. 2024 May;
16(747):eadi2952.
PMID: 38748775
Apart from their killer identity, natural killer (NK) cells have integral roles in shaping the tumor microenvironment. Through immune gene deconvolution, the present study revealed an interplay between NK cells...
3.
Neo S, Oliveira M, Tong L, Chen Y, Chen Z, Cismas S, et al.
J Exp Clin Cancer Res
. 2024 Jan;
43(1):13.
PMID: 38191418
Background: Inflammation in the eye is often associated with aggravated ocular diseases such as uveal melanoma (UM). Poor prognosis of UM is generally associated with high potential of metastatic liver...
4.
Tong L, Kremer V, Neo S, Liu Y, Chen Y, Wagner A, et al.
Cancer Commun (Lond)
. 2023 Jun;
43(7):855-859.
PMID: 37314951
No abstract available.
5.
Strickland M, Lee S, Neo S, Balachander A, Low I, Mustafah S, et al.
Biology (Basel)
. 2023 Apr;
12(4).
PMID: 37106796
Human ageing is accompanied by poor responses to infection and decreased vaccine efficacy. While the causes of this can be attributed to defects in the immune system that increase with...
6.
Neo S, Xu S, Chong J, Lam K, Wu J
J Immunother Cancer
. 2023 Apr;
11(4).
PMID: 37100458
Cell therapy encompasses an expanding spectrum of cell-based regimes for the treatment of human ailments, such as the use of immune cells, in particular T cells, for combating tumors and...
7.
Zhao J, Lee K, Toh H, Lam K, Neo S
Front Pharmacol
. 2023 Apr;
14:1163160.
PMID: 37063269
The dysregulation of the biochemical pathways in cancer promotes oncogenic transformations and metastatic potential. Recent studies have shed light on how obesity and altered lipid metabolism could be the driving...
8.
Chen Z, Tong L, Neo S, Li S, Gao J, Schlisio S, et al.
Oncoimmunology
. 2023 Mar;
12(1):2175517.
PMID: 36970070
Infusion of natural killer (NK) cells is an attractive therapeutic modality in patients with cancer. However, the activity of NK cells is regulated by several mechanisms operating within solid tumors....
9.
Chen X, Sifakis E, Robertson S, Neo S, Jun S, Tong L, et al.
Proc Natl Acad Sci U S A
. 2022 Dec;
120(1):e2209856120.
PMID: 36574653
Breast cancer (BC) is a complex disease comprising multiple distinct subtypes with different genetic features and pathological characteristics. Although a large number of antineoplastic compounds have been approved for clinical...
10.
Neo S, Jing X, Tong L, Tong D, Gao J, Chen Z, et al.
J Immunother Cancer
. 2022 Oct;
10(10).
PMID: 36283735
Downregulation of MHC class I (MHCI) molecules on tumor cells is recognized as a resistance mechanism of cancer immunotherapy. Given that MHCI molecules are potent regulators of immune responses, we...